Search

Your search keyword '"Olinvyk (Medication)"' showing total 7 results
Start Over Descriptor "Olinvyk (Medication)" Journal legal monitor worldwide
7 results on '"Olinvyk (Medication)"'

1. Trevena Announces Two OLINVYK Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY 2021

Subjects
Trevena Inc., Executives, Medical societies, Pharmaceutical industry, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the acceptance [...]

Published
2021

2. Trevena Announces Wake Forest Baptist Health Joining OLINVYK Clinical Outcomes Study

Subjects
Trevena Inc., Pharmaceutical industry, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced Wake Forest [...]

Published
2021

3. Trevena Announces Initiation of OLINVYK Respiratory Physiology Study Including Elderly|Obese Subjects

Subjects
Trevena Inc., Aged -- Physiological aspects, Respiratory agents -- Physiological aspects, College teachers -- Physiological aspects, Pharmaceutical industry -- Physiological aspects, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced it has [...]

Published
2021

4. Trevena Announces Presentations of OLINVYK Health Economic Models at ISPOR 2021

Subjects
Trevena Inc., Conferences and conventions -- Economic aspects, Pharmaceutical industry -- Economic aspects, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced two poster [...]

Published
2021

5. Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors

Subjects
Trevena Inc. -- Officials and employees, Corporate directors, Pharmaceutical industry -- Officials and employees, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Marvin [...]

Published
2021

6. Trevena, Inc. Announces Publication Highlighting OLINVYK Respiratory Safety Data in High-Risk Patients in Pain & Therapy

Subjects
Trevena Inc., College teachers, Body mass index, Pharmaceutical industry, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the publication [...]

Published
2021

7. Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection

Subjects
United States. Drug Enforcement Administration, Trevena Inc., Tapentadol, Pharmaceutical industry, Drug approval, Business, international, Law, Olinvyk (Medication)
Abstract

(GlobeNewswire) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that oliceridine [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results